Overview
Chia Goh practices practicing medicine in Newcastle Upon Tyne, United Kingdom.
Goh is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Triple-Negative Breast Cancer, Breast Cancer, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Smoldering Multiple Myeloma.
They are actively involved in clinical research, co-authoring 8 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Chia Y. Goh
Is Chia Y. Goh a top-rated expert for Triple-Negative Breast Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Chia Y. Goh is classified as an Advanced expert for Triple-Negative Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Chia Y. Goh participate in research or clinical trials?
Yes. Chia Y. Goh has published 8 articles and abstracts on conditions like Triple-Negative Breast Cancer. You can view a list of Chia Y. Goh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Triple-Negative Breast Cancer
- Experienced
- Breast CancerGoh isExperienced. Learn about Breast Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Smoldering Multiple Myeloma